Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET/CT Scans For Tumor Staging
NCT00499382 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2012-08-01
Summary
Primary Objective:
* Evaluate the agreement between radionuclide ventriculography (RNV) and gated F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in calculating left ventricular ejection fraction (LVEF), end diastolic volume (EDV) and end systolic volume (ESV).
Conditions
Interventions
- PROCEDURE
-
Nuclear Medicine Cardiac Scan
Scan lasting 30 minutes while being hooked up to a heart monitor that takes pictures every time your heart beats.
- PROCEDURE
-
PET/CT Cardiac Scan
Scan lasting 10-15 minutes and performed after the normally scheduled PET/CT scan.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Isis W. Gayed, MD · M.D. Anderson Cancer Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-09-30
- Primary Completion
- 2009-03-31
- Completion
- 2009-03-31
Countries
- United States
Study Locations
More Related Trials
-
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
NCT00424138 ·Status: TERMINATED ·Phase: NA
-
18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors
NCT04258592 ·Status: TERMINATED ·Phase: PHASE1
-
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
NCT00110006 ·Status: WITHDRAWN ·Phase: NA
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
NCT00707213 ·Status: TERMINATED ·Phase: PHASE1
-
Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma
NCT04367948 ·Status: UNKNOWN ·Phase: NA
-
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
NCT01931709 ·Status: TERMINATED ·Phase: NA
-
18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer
NCT06414902 ·Status: RECRUITING ·Phase: PHASE1
-
18F-FDG Tomography and Labeled Leukocyte Scintigraphy
NCT05994768 ·Status: COMPLETED
-
Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery
NCT02112162 ·Status: TERMINATED ·Phase: PHASE1
-
Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation
NCT04488094 ·Status: COMPLETED ·Phase: PHASE2
-
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
NCT06549413 ·Status: ACTIVE_NOT_RECRUITING
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Diffuse Large B-cell Lymphoma
NCT02931201 ·Status: UNKNOWN ·Phase: NA
-
Cardiac Perfusion and Metabolism With [11C] Acetate PET/CT is Associated With Hematopoietic System Activation in Acute Decompensated Heart Failure: An Imaging Sub-study
NCT03924102 ·Status: WITHDRAWN ·Phase: PHASE1
-
F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer
NCT06789562 ·Status: NOT_YET_RECRUITING
-
Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis
NCT05062395 ·Status: COMPLETED
-
Ultralow Dose PET Imaging of 18F-FDG Uptake
NCT06956391 ·Status: RECRUITING ·Phase: PHASE2
-
18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
NCT02079181 ·Status: TERMINATED ·Phase: NA
-
Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET
NCT07285993 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Pilot Study Evaluating the Potential of 18F Fluorodeoxyglucose PET-CT Imaging in Diagnosing Cardiac Rejection.
NCT06519240 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Added Value of PET/CT in Lung Cancer
NCT06494800 ·Status: NOT_YET_RECRUITING
-
Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
NCT00499395 ·Status: COMPLETED ·Phase: NA
-
FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies
NCT00880074 ·Status: COMPLETED ·Phase: PHASE1
-
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
NCT04678440 ·Status: COMPLETED ·Phase: EARLY_PHASE1